ArticleBioengineered2024

Statement of Retraction: Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer.

No numbers read from the abstract.

Not cited yet